Dr. Clive Dix

Carrick Therapeutics

Dr. Dix has 30 years’ experience of drug discovery and development, and currently serves as CEO of C4X Discovery Holdings. He co-founded and was chief executive of both Convergence Pharmaceuticals Ltd and PowerMed Ltd, which were acquired by Biogen and Pfizer respectively. Prior to moving into the biotechnology sector, Dr. Dix was UK research director for GlaxoWellcome. He is currently chairman of Touchlight Genetics Ltd and Centauri Therapeutics Ltd, and served as chairman of the UK BioIndustry Association from 2008-2010.